Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Tuspetinib for AML
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • Tuspetinib for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Join Us
    • Values & Culture
    • Perks & Benefits
    • Explore Careers
  • Contact

Press Releases

News

News

  • Press Releases
  • Presentations
  • Events

Aptose To Release Second Quarter Ended June 30, 2017 Financial Results and Hold Conference Call on August 8, 2017

Aug 01, 2017 8:30am EDT

Aptose Biosciences Announces Results of Annual Meeting of Shareholders

Jun 06, 2017 4:05pm EDT

Aptose Reports Results for the First Quarter Ended March 31, 2017

May 11, 2017 4:02pm EDT

Preclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies Meeting

May 08, 2017 8:00am EDT

OHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies Meeting

May 08, 2017 8:00am EDT

Aptose Biosciences to Participate at the Bloom Burton & Co. Healthcare Investor Conference 2017

Apr 25, 2017 8:30am EDT

Aptose To Release First Quarter Ended March 31, 2017 Financial Results and Hold Conference Call on May 11, 2017

Apr 24, 2017 8:30am EDT

Aptose Biosciences to Present CG’806 Data at AACR Hematologic Malignancies Meeting

Apr 19, 2017 8:30am EDT

Aptose Reports Fourth Quarter and Year End 2016 Results

Mar 28, 2017 5:03pm EDT

Aptose Announces Planned Departure of Chief Business Officer

Mar 27, 2017 8:00am EDT
RSS
  • Prev
    • 1...
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • ...33
    Next
    © 2025 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Clinical Trials Policy Disclaimer Sitemap Manage Cookie Preferences